Sample size calculations for clinical trials targeting tauopathies: a new potential disease target

The evolution of primary progressive apraxia of speech

(2014) Keith A. Josephs et al.   BRAIN

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

(2014) Adam L Boxer et al.   LANCET NEUROLOGY

A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

(2014) Eduardo Tolosa et al.   MOVEMENT DISORDERS

Rate of decline in progressive supranuclear palsy

(2014) Irene Litvan et al.   MOVEMENT DISORDERS

Rates of  -amyloid accumulation are independent of hippocampal neurodegeneration

(2014) C. R. Jack et al.   NEUROLOGY

The apraxia of speech rating scale: A tool for diagnosis and description of apraxia of speech

(2014) Edythe A. Strand et al.   JOURNAL OF COMMUNICATION DISORDERS

Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: An MRI and FDG-PET study

(2013) Jennifer L. Whitwell et al.   BRAIN AND LANGUAGE

Aphasia with left occipitotemporal hypometabolism: A novel presentation of posterior cortical atrophy?

(2013) Meredith R. Wicklund et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA

(2013) K. A. Josephs et al.   NEUROLOGY

Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech

(2012) Keith A. Josephs et al.   BRAIN

Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy

(2012) J. L. Whitwell et al.   EUROPEAN JOURNAL OF NEUROLOGY

Algorithms, atrophy and Alzheimer's disease: Cautionary tales for clinical trials

(2011) Nick C. Fox et al.   NEUROIMAGE

Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: Determining sample size for treatment trials

(2011) Jennifer L. Whitwell et al.   PARKINSONISM & RELATED DISORDERS

Neuropathology of variants of progressive supranuclear palsy

(2010) Dennis W Dickson et al.   CURRENT OPINION IN NEUROLOGY

Mapping Alzheimer's disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals

(2010) Xue Hua et al.   NEUROIMAGE

Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjects

(2009) Xue Hua et al.   NEUROIMAGE

Prediction of pathology in primary progressive language and speech disorders

(2009) V. Deramecourt et al.   NEUROLOGY